Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoEHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress PR Newswire SUZHOU, China and ROCKVILLE, Md., May 15, 2024 SUZHOU, China and ROCKVILLE
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoTurning now to the progress we have made with our lead product candidate, prexigebersen. As you know, last year, we reported positive interim results from Stage 2 of our Phase 2 clinical trial ...
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA)...
WTRF Wheeling· 5 days agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
What Is Immunophenotyping?
Healthline· 6 days agoImmunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases....
Affimed (NASDAQ:AFMD) Short Interest Update
ETF DAILY NEWS· 4 days agoAffimed (NASDAQ:AFMD – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 204,100 shares, ...
Virginia Tech researchers join together on cancer | Newswise
Newswise· 4 days agoMay is both Brain Tumor Awareness Month and National Cancer Research Month. Virginia Tech’s Fralin Biomedical Research Institute at VTC is dedicated to advancing health through a better understanding ...
Sutro Biopharma shares hold on luvelta prospects By Investing.com
Investing.com· 7 days agoLuvelta has the potential to serve a larger population than AbbVie (NYSE...Biopharma plans to...
Former patients reunite as professionals at UPMC Children's Hospital of Pittsburgh
Pittsburgh Tribune-Review· 4 days agoDr. Matt Kocher was setting up an operating room during his anesthesia fellowship at UPMC Children’s...
Curis Announces Additional Data from TakeAim Leukemia Study
WRBL Columbus· 6 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced updated data from ...
Brookfield cancer patient gets ‘a second chance on life’ with stem cells from a Canadian athlete
The News-Times· 7 days agoSubmission of a sample to a national donor program sparked an unexpected connection between a...
